08:00 , Jan 26, 2015 |  BC Week In Review  |  Clinical News

AmpliVue Bordetella Assay regulatory update

FDA granted 510(k) clearance to Quidel’s AmpliVue Bordetella Assay to detect Bordetella pertussis nucleic acids isolated from nasopharyngeal swab specimens obtained from patients with respiratory tract infection. Quidel said the product is now available in...